Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 120

Results For "portfolio"

1611 News Found

ALPLA acquires Polish packaging manufacturer APON
News | July 08, 2022

ALPLA acquires Polish packaging manufacturer APON

The acquisition continues the growth and expansion course of the ALPLApharma business division established in 2019


Evonik launches non-animal-derived collagen platform for medical device applications
News | July 08, 2022

Evonik launches non-animal-derived collagen platform for medical device applications

Fermentation-based manufacturing leverages Evonik’s biotechnology platform


Biocon Biologics receives EU GMP Certification for its in Bengaluru
News | July 06, 2022

Biocon Biologics receives EU GMP Certification for its in Bengaluru

This integrated, multi-product facility houses manufacturing suites, analytical testing laboratories and warehousing.


StimLabs announces new placental membrane-based product ‘Enverse’
News | July 06, 2022

StimLabs announces new placental membrane-based product ‘Enverse’

The introduction of Enverse is part of StimLabs' aim to simplify patient care for both physicians and the hospital systems


JB Pharma acquires 4 paediatric brands from Dr Reddy’s Laboratories
News | July 01, 2022

JB Pharma acquires 4 paediatric brands from Dr Reddy’s Laboratories

The total covered market size of four brands – Z&D, Pediclory, Pecef & Ezinapi combined is Rs 1800 crores


Wacker to build biotechnology center in Munich
Biotech | June 28, 2022

Wacker to build biotechnology center in Munich

The research here will mainly concentrate on the manufacturing process of biopharmaceuticals, especially in the area of advanced medicines, as well as the fermentation-based manufacture of ingredients for foods and food supplements


Astellas’s update on the Fortis clinical trial of AT845 in adults for pompe disease
Drug Approval | June 27, 2022

Astellas’s update on the Fortis clinical trial of AT845 in adults for pompe disease

The FDA informed Astellas that it did not have sufficient information to assess the risks to subjects


IOL Life Sciences incorporated as a subsidiary of IOL Chemicals and Pharmaceuticals
News | June 22, 2022

IOL Life Sciences incorporated as a subsidiary of IOL Chemicals and Pharmaceuticals

The company is strategically expanding its product portfolio with a pipeline of new products that will form a strong foundation for future growth.


Merck appoints Chirfi Guindo as CMO for Merck Human Health
People | June 22, 2022

Merck appoints Chirfi Guindo as CMO for Merck Human Health

Guindo will be responsible for leading the development and implementation of the company’s long-term strategy for the Human Health portfolio.